Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lasser, Robert A.
Bossie, Cynthia A.
Gharabawi, Georges M.
and
Turnerb, Martin
2004.
Mejorías clínicas significativas con risperidona de larga duración en pacientes con esquizofrenia previamente estables con neurolépticos depote convencionales.
European psychiatry (Ed. Española),
Vol. 11,
Issue. 6,
p.
341.
Chue, Pierre S.
D'Hoore, Peter
and
Michael Ramstack, J.
2004.
Sustained drug delivery optimizes long-term treatment of patients with schizophrenia.
Acta Neuropsychiatrica,
Vol. 16,
Issue. 6,
p.
319.
Ehret, Megan J
and
Fuller, Matthew A
2004.
Long-Acting Injectable Risperidone.
Annals of Pharmacotherapy,
Vol. 38,
Issue. 12,
p.
2122.
2005.
Current awareness in human psychopharmacology.
Human Psychopharmacology: Clinical and Experimental,
Vol. 20,
Issue. 1,
p.
75.
M??ller, Hans-J??rgen
Llorca, Pierre-Michel
Sacchetti, Emilio
Martin, Stephen D
Medori, Rossella
and
Parellada, Eduard
2005.
Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies.
International Clinical Psychopharmacology,
Vol. 20,
Issue. 3,
p.
121.
Ereshefsky, Larry
and
Mannaert, Erik
2005.
Pharmacokinetic Profile and Clinical Efficacy of Long-Acting Risperidone.
Drugs in R & D,
Vol. 6,
Issue. 3,
p.
129.
Möller, Hans-Jürgen
2005.
Risperidone: a review.
Expert Opinion on Pharmacotherapy,
Vol. 6,
Issue. 5,
p.
803.
Lasser, Robert A.
Bossie, Cynthia A.
Gharabawi, Georges M.
and
Kane, John M.
2005.
Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection.
Schizophrenia Research,
Vol. 77,
Issue. 2-3,
p.
215.
Gastpar, M.
Masiak, M.
Latif, M. A.
Frazzingaro, S.
Medori, R.
and
Lombertie, E. -R.
2005.
Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine.
Journal of Psychopharmacology,
Vol. 19,
Issue. 5_suppl,
p.
32.
BURTON, SIMON C.
2005.
Strategies for Improving Adherence to Second-Generation Antipsychotics in Patients with Schizophrenia by Increasing Ease of Use.
Journal of Psychiatric Practice,
Vol. 11,
Issue. 6,
p.
369.
Jarboe, Kathleen S.
Littrell, Kimberly
and
Tugrul, Karen
2005.
Long-Acting Injectable Risperidone: An Emerging Tool in Schizophrenia Treatment.
Journal of Psychosocial Nursing and Mental Health Services,
Vol. 43,
Issue. 12,
p.
25.
Haycox, Alan
2005.
Pharmacoeconomics of long-acting risperidone: Results and validity of cost-effectiveness models.
PharmacoEconomics,
Vol. 23,
Issue. S1,
p.
3.
De Graeve, Diana
Smet, Ann
Mehnert, Angelika
Caleo, Sue
Miadi-Fargier, Houda
Mosqueda, Guillermo Jasso
Lecompte, Damien
and
Peuskens, Joseph
2005.
Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis.
PharmacoEconomics,
Vol. 23,
Issue. S1,
p.
35.
LINDENMAYER, JEAN-PIERRE
PARAK, MOHAN
and
GORMAN, JACK M.
2006.
Improved Long-Term Outcome with Long-Acting Risperidone Treatment of Chronic Schizophrenia with Prior Partial Response.
Journal of Psychiatric Practice,
Vol. 12,
Issue. 1,
p.
55.
Ravasio, Roberto
and
Ferrannini, L.
2006.
Costo-efficacia di risperidone iniettabile a rilascio prolungato nel trattamento della schizofrenia in Italia.
PharmacoEconomics Italian Research Articles,
Vol. 8,
Issue. 1,
p.
19.
Murphy, Brendan P.
Chung, Young-Chul
Park, Tae-Won
and
McGorry, Patrick D.
2006.
Pharmacological treatment of primary negative symptoms in schizophrenia: A systematic review.
Schizophrenia Research,
Vol. 88,
Issue. 1-3,
p.
5.
Vauth, Roland
and
Stieglitz, Rolf-Dieter
2006.
Der Stellenwert von Kombinationsbehandlung in der Versorgung schizophrener Störungen.
Zeitschrift für Psychiatrie, Psychologie und Psychotherapie,
Vol. 54,
Issue. 3,
p.
173.
Llorca, Pierre-Michel
Kahn, Jean-Pierre
Moreau-Mallet, Véronique
Bouhours, Philippe
and
the French StoRMi investigators gro
2006.
Symptom control, functioning, and hospitalization status in French patients changed from oral atypical antipsychotics to risperidone long-acting injectable.
International Journal of Psychiatry in Clinical Practice,
Vol. 10,
Issue. 4,
p.
276.
Parellada, Eduard
2006.
Clinical experience and management considerations with long-acting risperidone.
Current Medical Research and Opinion,
Vol. 22,
Issue. 2,
p.
241.
Nick, Beat
Vauth, Roland
Braendle, Daniel
Riecher-Rössler, Anita
and
THE SWISS StoRMi INVESTIGATORS GROU
2006.
Symptom control, functioning and satisfaction among Swiss patients treated with risperidone long-acting injectable.
International Journal of Psychiatry in Clinical Practice,
Vol. 10,
Issue. 3,
p.
174.
Comments
No Comments have been published for this article.